Xencor (XNCR) Shares Outstanding (Weighted Average) (2013 - 2026)

Xencor (XNCR) reported Shares Outstanding (Weighted Average) of $75.2 million for Q1 2026, up 2.14% year-over-year from $73.7 million in Q1 2025, and up 1.36% quarter-over-quarter from $74.2 million in Q4 2025.

Xencor (XNCR) Shares Outstanding (Weighted Average) (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Shares Outstanding (Weighted Average) data on file, last reported at $75.2 million in Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $75.2 million, up 2.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $75.2 million (up 2.14% YoY), and the FY2025 annual result was $74.2 million, up 14.14% from the prior year.
  • Shares Outstanding (Weighted Average) climbed to $75.2 million in Q1 2026 per XNCR's latest filing, from $74.2 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $75.2 million in Q1 2026 and troughed at $59.4 million in Q1 2022.
  • A 5-year average of $64.7 million and a median of $61.2 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Weighted Average) increased 0.4% in 2023, then gained 20.43% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $59.7 million in 2022, then advanced by 1.43% to $60.5 million in 2023, then advanced by 7.5% to $65.0 million in 2024, then advanced by 14.14% to $74.2 million in 2025, then advanced by 1.36% to $75.2 million in 2026.
  • Business Quant data shows XNCR's Shares Outstanding (Weighted Average) at $75.2 million in Q1 2026, $74.2 million in Q4 2025, and $74.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Xencor 953.38 Mn 878.64 Mn - 75.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 75.25 Mn
Dec 31, 2025 74.24 Mn
Sep 30, 2025 74.41 Mn
Jun 30, 2025 74.28 Mn
Mar 31, 2025 73.67 Mn
Dec 31, 2024 65.04 Mn
Sep 30, 2024 62.31 Mn
Jun 30, 2024 61.68 Mn
Mar 31, 2024 61.21 Mn
Dec 31, 2023 60.50 Mn
Sep 30, 2023 60.39 Mn
Jun 30, 2023 59.81 Mn
Mar 31, 2023 59.77 Mn
Dec 31, 2022 59.65 Mn
Sep 30, 2022 59.56 Mn
Jun 30, 2022 59.57 Mn
Mar 31, 2022 59.41 Mn
Dec 31, 2021 58.38 Mn
Sep 30, 2021 58.20 Mn
Jun 30, 2021 58.12 Mn